Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

ClinicalTrials.gov ID: NCT07221253

Public ClinicalTrials.gov record NCT07221253. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 8, 2026, 5:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III, Randomized, Open-label, Global, Multicenter Study of Rilvegostomig or Durvalumab in Combination With Chemotherapy as a First-line Treatment for Patients With Advanced Biliary Tract Cancer (ARTEMIDE-Biliary02)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to measure the efficacy and safety of rilvegostomig with gemcitabine plus cisplatin vs. durvalumab with gemcitabine plus cisplatin as first line treatment for patients with advanced BTC.

Study identification

NCT ID
NCT07221253
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,100 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 3, 2025
Primary completion
Jul 30, 2029
Completion
Jul 30, 2029
Last update posted
Aug 20, 2026

2025 – 2029

United States locations

U.S. sites
37
U.S. states
22
U.S. cities
32
Facility City State ZIP Site status
Research Site Birmingham Alabama 35205 Not yet recruiting
Research Site Phoenix Arizona 85054 Recruiting
Research Site Tucson Arizona 85719 Recruiting
Research Site Duarte California 91010 Recruiting
Research Site Los Angeles California 90095 Recruiting
Research Site Orange California 92868 Recruiting
Research Site Palo Alto California 94304 Recruiting
Research Site Aurora Colorado 80045 Recruiting
Research Site Hartford Connecticut 06102 Not yet recruiting
Research Site New Haven Connecticut 06510 Recruiting
Research Site Washington D.C. District of Columbia 20007 Recruiting
Research Site Washington D.C. District of Columbia 20037 Not yet recruiting
Research Site Gainesville Florida 32610 Recruiting
Research Site Jacksonville Florida 32224 Recruiting
Research Site Marietta Georgia 30060 Recruiting
Research Site Chicago Illinois 60612 Not yet recruiting
Research Site Chicago Illinois 60637 Not yet recruiting
Research Site Indianapolis Indiana 46202 Not yet recruiting
Research Site Louisville Kentucky 40217 Recruiting
Research Site Louisville Kentucky 40241 Not yet recruiting
Research Site Baltimore Maryland 21231 Recruiting
Research Site Ann Arbor Michigan 48109 Not yet recruiting
Research Site Detroit Michigan 48202 Not yet recruiting
Research Site Rochester Minnesota 55905 Recruiting
Research Site Omaha Nebraska 68198-5885 Not yet recruiting
Research Site Santa Fe New Mexico 87505 Recruiting
Research Site New York New York 10016 Not yet recruiting
Research Site New York New York 10032 Recruiting
Research Site New York New York 10065 Withdrawn
Research Site Portland Oregon 97239 Not yet recruiting
Research Site Lancaster Pennsylvania 17601 Recruiting
Research Site Philadelphia Pennsylvania 19111 Not yet recruiting
Research Site Pittsburgh Pennsylvania 15212 Recruiting
Research Site Providence Rhode Island 02903 Recruiting
Research Site Pierre South Dakota 57501 Recruiting
Research Site Sioux Falls South Dakota 57105 Recruiting
Research Site Houston Texas 77030 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 139 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07221253, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2026 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07221253 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →